Hormone Health

TRT in New Jersey: Who Can Prescribe It and What the Law Says

TRT in New Jersey is prescription care, and the prescription is where the rules live. Testosterone is a Schedule III controlled substance, New Jersey reaches that schedule by adopting the federal drug lists by reference, and the clinician who writes for you must hold a New Jersey license under Title 45. Protocol Health treats New Jersey patients by telehealth only; its one in-person clinic is in Scarsdale, New York.

Hormone HealthNew JerseyTRTTelehealthMen's Health

Medically reviewed by Richard Dentico, MD

TRT in New Jersey: Who Can Prescribe It and What the Law Says

How It Works

How TRT in New Jersey Actually Works

TRT in New Jersey runs on video for most men, and the sequence matters more than the setting. A clinician licensed to treat patients located in New Jersey takes a history, orders bloodwork, reads it, and writes for testosterone only when the labs and the symptoms agree. That order of operations is what separates a practice from a storefront:

  • A symptom history first. Fatigue, a lower sex drive and slower recovery bring most men in, and every one of those has explanations other than testosterone.
  • Fasting morning bloodwork, drawn twice. The Endocrine Society's testosterone guideline (PMID 29562364) recommends a fasting morning total testosterone as the initial test, repeated on a second morning before any diagnosis.
  • A prescription written against the numbers, with a documented reason to treat or not to.
  • Repeat panels on a calendar. Hematocrit, PSA and estradiol all move on testosterone, and the panel is how the prescriber sees it.

Protocol Health runs TRT for men in that order for New Jersey patients, by video and by mail, with blood drawn at a lab near you. There is no Protocol Health office in New Jersey.

Book a TRT consultation

Who Can Prescribe

Who Can Legally Prescribe TRT in New Jersey?

Only a clinician licensed in New Jersey may prescribe TRT to a patient located in New Jersey, and the state statute is unusually blunt about it. A provider using telemedicine must, in the words of the enacted law, "be validly licensed, certified, or registered, pursuant to Title 45 of the Revised Statutes, to provide such services in the State of New Jersey," must remain subject to the New Jersey licensing board, and remains subject to New Jersey jurisdiction. That language is section 2 of P.L. 2017, c.117, now N.J.S.A. 45:1-62, as amended by P.L. 2021, c.310.

New Jersey offers no side door around that. Florida lets an out-of-state clinician register as a telehealth provider and prescribe without a Florida license; we know of no equivalent out-of-state telehealth registration in New Jersey. The prescriber must hold New Jersey authorization under Title 45 or does not prescribe here.

The consequence runs opposite to what most men assume. The clinic's street address grants nothing. What the license has to match is where you are sitting — Hoboken, Cherry Hill, Paramus, Toms River — so a practice with no New Jersey office can still be the right one, provided its clinician holds New Jersey authorization.

Schedule III

Testosterone Is Schedule III, and New Jersey Adopts the Federal Schedules

Testosterone is a Schedule III controlled substance, and New Jersey arrives there by adoption rather than by writing it out. The federal Anabolic Steroids Control Act of 1990 placed anabolic steroids — defined as substances chemically and pharmacologically related to testosterone — in Schedule III of the Controlled Substances Act. New Jersey has adopted the federal Schedule I through V lists by reference under N.J.S.A. 24:21-3(c) and N.J.A.C. 13:45H-10.1, so anabolic steroids sit on the New Jersey schedules even though the list printed in the statute at N.J.S.A. 24:21-7 does not name them. The New Jersey Attorney General's Steroids Study Group set that mechanism out in its 2011 report.

This is where New Jersey and New York genuinely diverge, and the difference is not cosmetic. New York names testosterone in its own state schedule one tier above the federal listing, which pulls a New York prescription into a stricter state regime. New Jersey does not re-tier it. The federal Schedule III is the New Jersey Schedule III, and the rules that follow are the rules that attach to Schedule III.

Two things follow for a patient. Buying testosterone without a prescription is a controlled-substance offense in New Jersey, and every lawful route to it runs through a prescriber accountable for the decision.

In Person or Video

Do You Need an In-Person Visit to Start TRT in New Jersey?

New Jersey's telemedicine statute does not require an in-person visit before testosterone is prescribed. Its in-person requirement sits one schedule above testosterone. It permits prescribing a Schedule II controlled dangerous substance by telemedicine "only after an initial in-person examination of the patient," then every three months thereafter. Testosterone is Schedule III, so that statutory requirement does not reach it.

Two New Jersey rules do reach it, and they are the ones worth asking a clinic about:

  • No prescribing off a form. The same statute bars a provider from issuing a prescription "based solely on the responses provided in an online static questionnaire" unless a proper provider-patient relationship has already been established. That is New Jersey's plainest answer to the intake-form clinic.
  • A history and a full physical examination. The Board of Medical Examiners' rule at N.J.A.C. 13:35-7.1A requires an appropriate history and physical examination before a prescription, and a diagnosis based on that examination and the laboratory tests good medical care calls for. N.J.A.C. 13:35-7.9 goes further for anabolic steroids, testosterone included: a bona fide relationship with the patient, a medical history and a full physical examination establishing a documented medical indication. The telemedicine statute holds a video visit to the same standard of care as an in-person one, so ask any clinic, ours included, how its examination meets that rule.

Above it sits the federal layer, identical in every state. The Ryan Haight Act normally requires an in-person evaluation before a controlled substance is prescribed, and telemedicine is a statutory exception. The DEA and the Department of Health and Human Services have extended those flexibilities through December 31, 2026. The date is printed on the rule, and no clinic can promise you what follows it.

Protocol Health's in-person clinic is in Scarsdale, New York. New Jersey patients are seen by video, with blood drawn at a laboratory near home.

Risks

The Risks of Testosterone Therapy, Before the Reasons to Want It

Testosterone therapy carries risks that belong in the same paragraph as the case for it. A prescriber who cannot name them unprompted is not the right prescriber.

  • Fertility. Testosterone given from outside suppresses the body's own production, and sperm production can fall with it. The Endocrine Society guideline recommends against starting testosterone in men planning fertility in the near term. Enclomiphene, which is unapproved (not FDA-approved for any use), acts on the feedback loop rather than replacing testosterone; whether it fits is the prescriber's decision.
  • Hematocrit. Testosterone raises red cell mass, and a rise in hematocrit is among the most frequently reported adverse effects of testosterone therapy. Our guide to lowering hematocrit on TRT sets out what a monitoring plan looks like.
  • Prostate. PSA is followed during treatment. The guideline recommends against starting testosterone in men with prostate cancer, a palpable prostate nodule or induration, or a PSA above 4 ng/mL — above 3 ng/mL in men at increased risk — without further urological evaluation.
  • Conditions that rule it out. The same guideline recommends against starting testosterone in men with breast cancer, an elevated hematocrit, untreated severe obstructive sleep apnea, severe lower urinary tract symptoms, uncontrolled heart failure, a heart attack or stroke within the previous six months, or thrombophilia.
  • Cardiovascular safety. The TRAVERSE trial randomized 5,246 men aged 45 to 80 with hypogonadism and existing or high cardiovascular risk to transdermal testosterone or placebo. A major adverse cardiac event occurred in 7.0% on testosterone and 7.3% on placebo, meeting the trial's noninferiority margin. The same trial recorded more atrial fibrillation, acute kidney injury and pulmonary embolism on testosterone (TRAVERSE, New England Journal of Medicine, 2023).

None of that argues against treatment. It argues for a prescriber who measures, and for treating the monitoring panel as therapy rather than upsell.

Cost

What a TRT Price in New Jersey Leaves Out

A TRT price in New Jersey has four lines, and an advertised monthly figure usually covers one: the consultation, the baseline bloodwork, the medication, and the repeat panels that decide whether treatment continues. The fourth vanishes from pricing pages, and it is the one that makes treatment safe.

Insurance coverage varies, and many of the New Jersey clinic pages we reviewed quote a flat cash price. A flat price is not a red flag; a flat price with no stated inclusions is. Three questions turn a headline number into a real one:

  • What does a full twelve months cost, bloodwork included? Follow-up panels are neither optional nor free.
  • Is the medication billed by the clinic or by the pharmacy? Frequently the pharmacy, and separately.
  • What happens if the labs say stop? Ask whether a prepaid package survives a clinical no.

Our Approach

TRT at Protocol Health: New Jersey by Telehealth, Scarsdale in Person

Protocol Health is a physician-led longevity practice in Scarsdale, New York. It sees patients in person at the Scarsdale clinic and by telehealth in New York, New Jersey, Connecticut, Florida and California. There is no Protocol Health office in New Jersey.

Protocol Health prescribes testosterone therapy, anastrozole alongside it where estradiol management is clinically warranted, and enclomiphene. We have a commercial interest in this subject and say so here, which is why this page rests on the New Jersey statute and the federal schedule rather than on what a clinic would prefer to be true. Three points of regulatory status, stated plainly:

  • Testosterone cypionate, enanthate and undecanoate injections are FDA-approved drugs; compounded testosterone preparations are not FDA-approved. Prescribing them for age-related low testosterone is an off-label use.
  • Anastrozole is an approved drug. Using it alongside TRT in men is also off-label, is not routine, and is an individual decision made with the prescriber who knows your estradiol results.
  • Enclomiphene is unapproved — not FDA-approved for any use.

The treating clinician decides whether testosterone is appropriate, in which form and at what dose, against your labs and history. This page sets no dose and gives no individual advice. Start with the two-minute health quiz, or read what advanced lab testing covers.

FAQ

Frequently Asked Questions

Is TRT legal in New Jersey?

Yes, with a prescription from a clinician licensed in New Jersey. Testosterone is a Schedule III controlled substance, so buying and self-injecting it without a prescription is an offense. What governs is where the patient is located, not where the clinic keeps an office.

Is testosterone a controlled substance in New Jersey?

Yes, in Schedule III. The Anabolic Steroids Control Act of 1990 placed anabolic steroids in federal Schedule III, and New Jersey adopts the federal lists by reference under N.J.S.A. 24:21-3(c) and N.J.A.C. 13:45H-10.1. New Jersey does not re-list testosterone in a higher state schedule the way New York does.

Can you get TRT through telehealth in New Jersey?

Yes, when the prescriber holds a New Jersey license under Title 45, because the patient's location governs rather than the clinic's address. We know of no out-of-state telehealth registration in New Jersey, so a clinician without New Jersey authorization cannot prescribe to you here.

Do you need an in-person exam to start TRT in New Jersey?

Not under the telemedicine statute, as of October 2026. It requires an in-person examination before a Schedule II controlled dangerous substance is prescribed; testosterone is Schedule III, so that requirement does not apply. The Board's anabolic-steroid rule, N.J.A.C. 13:35-7.9, still requires a medical history and a full physical examination before testosterone is prescribed, held by statute to the same standard of care by video as in person. The federal Ryan Haight rule sits above it, with telemedicine flexibilities extended through December 31, 2026, so confirm the current position with the clinic.

Can a clinic prescribe TRT from an online questionnaire in New Jersey?

No. N.J.S.A. 45:1-62 bars a provider from issuing a prescription based solely on the responses in an online static questionnaire unless a proper provider-patient relationship already exists. The Board of Medical Examiners separately requires a history and physical examination before a prescription is written, and a full physical examination for anabolic steroids, testosterone included.

Does Protocol Health have a clinic in New Jersey?

No. Protocol Health's only in-person clinic is in Scarsdale, New York. New Jersey patients are treated by telehealth, with labs drawn locally and medication shipped.

Explore

Related at Protocol Health

Book a TRT consultation

This article is educational and is not medical advice. It does not diagnose, prevent, treat or cure any condition. Talk with a licensed clinician about your own situation.